Why the study?
Does spironolactone improve cardiac oxidative stress, fibrosis, inflammation, and mitochondrial dysfunction in streptozotocin-induced diabetic rats?
Population
Streptozotocin-induced diabetic rats
Comparison
Spironolactone vs Streptozotocin + normal saline (STZ + NS group)
Design
Preclinical
Authors
Loading...
Hypothesis-generating for spironolactone in diabetic cardiomyopathy; leaves open clinical translation in humans.
Does spironolactone improve cardiac oxidative stress, fibrosis, inflammation, and mitochondrial dysfunction in streptozotocin-induced diabetic rats?
Spironolactone demonstrates cardioprotective effects in a rat model of diabetic cardiomyopathy by ameliorating mitochondrial dysfunction, fibrosis, oxidative stress, and inflammation.
Liu et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: